Also, group company Wockhardt Hospitals sold part of its hospital chain to Fortis for Rs 909 crore to repay loans. Relief was short-lived, though. From 2013, regulatory action by the American Food and Drug Administration (FDA) rocked the Indian pharmaceutical industry that was selling generic drugs in ...
Read more: How Wockhardt Chairman Habil Khorakiwala plans to pull the company out of trouble